Tuesday, August 6, 2019

Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment by KATIE THOMAS


By KATIE THOMAS

The failure to report the issue has not put patients at risk, the F.D.A. said, but the drugmaker could face criminal and civil penalties.

Published: August 5, 2019 at 08:00PM

from NYT Health https://ift.tt/2M3PJn4
via IFTTT



from WordPress https://ift.tt/2Yu2RZ3
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)